Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. (Q54032299)
Jump to navigation
Jump to search
scientific article published in October 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. |
scientific article published in October 2000 |
Statements
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. (English)
Levin VA
Uhm JH
Jaeckle KA
Choucair A
Flynn PJ
Yung WKA
Prados MD
Bruner JM
Chang SM
Kyritsis AP
Gleason MJ
Hess KR
1 October 2000
6
10
3878-3884